News | News By Subject | News by Disease News By Date | Search News

Prostate cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Bavarian Nordic (BAVA.CO) Plummets 49% After Cancer Vaccine Flunks Late-Stage Test     9/15/2017
Unknown Number of Employees Impacted as ESSA Pharma Restructures and Refocuses R&D     9/11/2017
Bristol-Myers Squibb (BMY), Clovis Oncology (CLVS) Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III     8/1/2017
Massachusetts’ Cellanyx Develops New Method to Culture Primary Prostate Cells     6/2/2017
Pfizer (PFE)'s Xtandi Flunks Late-Stage Study Against Johnson & Johnson (JNJ)'s Zytiga     12/16/2016
Taking a Closer Look at Nymox (NYMX)'s 'Overinflated' Prostate Drug Hype     8/29/2016
Struggling Tokai Pharma (TKAI) Nixes Enrollment in Mid-Stage Prostate Cancer Study     8/23/2016
Tokai Pharma (TKAI) Axes 60% of Workforce After Phase III Prostate Cancer Trial Failure     8/1/2016
Tokai Pharma (TKAI) to Terminate ARMOR3-SV Clinical Trial, Shares Tank     7/26/2016
ANI Pharma Snags FDA Approval and Immediate Launch of Nilutamide Tablets, The First Generic Competitor to Nilandron     7/18/2016
UCLA Sells Royalty Rights Connected with Cancer Drug to Royalty Pharma for $1.14 Billion     3/7/2016
Eagle Pharma (EGRX), Teikoku Pharma Win FDA Approval of Docetaxel Injection, First and Only Alcohol-Free Formulation     12/28/2015
ASCO15: Exelixis (EXEL) Results for Drug Combo Buoy the Flailing SF Biotech     6/1/2015
Ipsen (IPN.PA), Active Biotech AB (BTPC) Plummet As Prostate Cancer Drug Flunks Late-Stage Trial     4/17/2015
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine     3/5/2015

News from Around the Web
New Three-In-One Blood Test Opens Door To Precision Medicine For Prostate Cancer, The Institute of Cancer Research Study Reveals     6/19/2017
New Blood Test Uses Nanotechnology To Predict Aggressive Prostate Cancer Accurately     6/12/2017
Why Johnson & Johnson (JNJ)'s New Prostate Cancer Drug Could Spell Trouble For Pfizer (PFE)     6/7/2017
Gazing Into The Crystal Ball For Advaxis (ADXS): What To Expect At ASCO 2017     4/7/2017
Guys: You Don't Want That PSA Test For Prostate Cancer     4/4/2017
'Sniffing' Urine To Detect Prostate Cancer Could Prevent Unnecessary Biopsies, Journal of Urology Reveals     4/3/2017
Old Drug Gets New Trick For Prostate Cancer Treatment, Massachusetts General Hospital Reveals     2/3/2017
University of Pennsylvania Study Links Prostate Cancer Treatment To Dementia     10/14/2016
Ben Stiller Reveals Prostate Cancer Diagnosis, Says PSA Test Saved His Life     10/5/2016
New Prostate Cancer Tests Aim To Reduce The Death Rate     10/4/2016
New Prostate Cancer Test Strives To Slash Biopsies, Cleveland Diagnostics Reveals     7/7/2016
Robotic Rectum May Aid Prostate Cancer Diagnosis, Imperial College London Study     7/5/2016
University of Alabama at Birmingham Receives Cutting-Edge Robot To Diagnose And Support Treatment Of Prostate Cancer     6/9/2016
University of Virginia Researchers Work to Speed Prostate Cancer Detection     6/6/2016
BMI And Waist Size Linked To Prostate Cancer Risk, University of Oxford Study Finds     6/3/2016

Press Releases
Accuray Inc. (ARAY) Release:10-year Data Shows CyberKnife System Provides Excellent Long-Term Control Of Low-Risk Prostate Cancer     9/26/2017
American Society For Radiation Oncology Release: Immune Response Prognostic For Prostate Cancer Survival, Recurrence And Response To Radiation Therapy     9/25/2017
Inovio Pharma (INO) dMAB Constructs Shrink Prostate Tumors And Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Preclinical Studies     9/21/2017
Berg Broadens Relationship With The Department Of Defense (DoD) Center For Prostate Disease Research With New Predictive Biomarker Test For Prostate Cancer     9/19/2017
Janssen Biotech (JNJ) Submits Supplemental New Drug Application To U.S. FDA For ZYTIGA (Abiraterone Acetate) To Treat Men With Earlier Stages Of Metastatic Prostate Cancer     9/15/2017
Astellas (ALPMY), Pfizer (PFE)'s Prostate Cancer Drug Hits Late-Stage Trial Goals     9/14/2017
OncBioMune Meets Primary Objective In Trial Of Proscavax Immunotherapy Vaccine For Prostate Cancer     9/14/2017
Inovio Pharma (INO)’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise And Significantly Increased PSA Doubling Times In Patients With Recurrent Prostate Cancer     9/11/2017
Janssen-Cilag International NV (JNJ) Release: New Data Presented At ESMO 2017 Shows That Abiraterone Acetate Plus Prednisone Provides Benefits In Patient Reported Outcomes In Both Metastatic Hormone-Sensitive And Castration-Resistant Prostate Cancer     9/8/2017
Myriad Genetics (MYGN) Release: Hereditary Cancer Risk Assessment Is An Important Option For Prostate Cancer Patients During Prostate Cancer Awareness Month     9/7/2017
Augmenix Announces Positive Five-Year Long-Term Data Highlighting Significant Bowel And Sexual Quality Of Life Benefits For Prostate Cancer Patients Treated With Spaceoar Hydrogel     9/6/2017
Epic Sciences Release: Liquid Biopsy Tumor Heterogeneity Test Predicts Resistance To Targeted Therapy In Metastatic Prostate Cancer Patients     9/6/2017
Blue Earth Diagnostics Announces Late-Breaking Initial Results Of Fluciclovine (18F) PET/CT Impact On Clinical Management Of Recurrent Prostate Cancer At Upcoming ASTRO Annual Meeting     9/6/2017
Prostate Conditions Education Council Release: Study Finds Screening Linked To Reduced Risk For Prostate Cancer Death     9/5/2017
Augmenix Release: NICE Announces Interventional Procedure Guidance Supporting Use Of Hydrogel Spacer In Treatment Of Prostate Cancer In The UK     8/30/2017